Physician profile
Fernando E Silva
NPI 1194744763
$15,817.69
in general payments reported to CMS, 2019-2025
39 companies · $3,647 in 2025
The $3,647 reported for 2025 was more than what 77% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,988 · 2020: $3,485 · 2021: $786 · 2022: $1,000 · 2023: $1,469 · 2024: $1,442 · 2025: $3,647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,318 · Travel and Lodging: $2,240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,318.32 |
| Travel and Lodging | $2,239.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $6,877.28 | 2019-2025 | Excelsius Gps, Tibial Nail |
| Medtronic, INC. | $4,141.01 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Inceptiv |
| Si-Bone, INC. | $615.94 | 2020-2025 | |
| Abbvie INC. | $600.04 | 2022-2025 | Botox |
| Providence Medical Technology, INC. | $456.25 | 2020-2023 | |
| Alphatec Spine, INC | $420.27 | 2023-2025 | Other - Miscellaneous |
| Seaspine Orthopedics Corporation | $331.78 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $263.23 | 2022-2024 | Andexxa |
| Acuity Surgical Devices, LLC | $194.63 | 2024 | |
| Grt US Holding, INC. | $174.76 | 2021-2022 | |
| Cerapedics INC. | $150.12 | 2022-2024 | I-Factor Peptide Enhanced Bone Graft |
| Orthofix Medical, INC. | $131.56 | 2024 | 7d Surgical System |
| Lifenet Health | $126.53 | 2024 | Allograft Vmis Delivery System |
| Kuros Biosciences USA, INC | $123.69 | 2023 | |
| Stryker Corporation | $123.08 | 2020-2023 | Spinejack, Omnicurve |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Silva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.